羊膜の世界市場レポート 2025年

羊膜の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11.0％で28億6,000万米ドルに成長します。予測期間の成長は、用途の拡大、再生医療の発展、慢性疾患の有病率の上昇、人口動態の高齢化、臨床試験および研究に起因します。予測期間の主な動向には、患者中心のヘルスケア、抗炎症作用への注目、臨床検証および研究、生物学的ドレッシングの革新、カスタマイズおよび個別化治療などが含まれます。

予想される移植手術の増加は、近い将来、羊膜市場の成長を加速させると予想されます。移植は、ある人（ドナー）から別のレシピエントへの組織または臓器の外科的移植を伴います。羊膜は様々な移植手術に使用されています。例えば、NHS Blood and Transplant Annual Report and Accounts 2022-23によると、2022-23年の英国におけるドナー数は前年比2％増、移植件数は5％増と報告されています。このように、移植件数の増加が羊膜市場の発展を後押ししています。

慢性疾患の有病率の上昇は、今後の羊膜市場の成長を促進すると予測されています。慢性疾患とは、3ヶ月以上持続する病気で、時間の経過とともに悪化する可能性があります。羊膜の抗炎症作用や再生作用などのユニークな特性は、慢性疾患の管理、合併症の最小化、組織損傷の修復に効果的です。その汎用性により、様々な医療分野で使用することができ、慢性疾患の効果的な治療に対する需要に応えることができます。たとえば、スイスに本部を置く国連機関、世界保健機関の報告書によると、2050年までに新たに発生するがん患者は3,500万人を超え、2022年の推定2,000万人から77％増加すると予測されています。したがって、慢性疾患の蔓延が羊膜市場の拡大に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の羊膜市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の羊膜市場：成長率分析
• 世界の羊膜市場の実績：規模と成長、2019～2024年
• 世界の羊膜市場の予測：規模と成長、2024～2029年、2034年
• 世界の羊膜総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の羊膜市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 凍結保存羊膜
• 凍結乾燥羊膜
• 世界の羊膜市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 手術創
• 眼科
• その他
• 世界の羊膜市場：最終用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 外来手術センター（ASC）
• その他
• 世界の羊膜市場：凍結保存羊膜のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 脱水凍結保存羊膜
• 新鮮凍結保存羊膜
• 世界の羊膜市場：凍結乾燥羊膜のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 滅菌済み凍結乾燥羊膜
• 未滅菌凍結乾燥羊膜

第7章 地域別・国別分析

• 世界の羊膜市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の羊膜市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 羊膜市場：競合情勢
• 羊膜市場：企業プロファイル
  • Alliqua BioMedical Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Amnio Technology LLC Overview, Products and Services, Strategy and Financial Analysis
  • Applied Biologics LLC Overview, Products and Services, Strategy and Financial Analysis
  • Human Regenerative Technologies LLC Overview, Products and Services, Strategy and Financial Analysis
  • Rivela DermaScience Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• MiMedx Group Inc.
• Skye Biologics Inc.
• Amniox Medical Inc.
• Integra LifeSciences Co.
• Organogenesis Holdings Inc.
• Bio-Tissue Inc.
• Stryker Corporation
• Osiris Therapeutics Inc.
• Tissue-Tech Inc.
• DermaSciences Inc.
• Laboratoire CCD
• VIVEX Biologics Inc.
• Merakris Therapeutics Inc.
• Thea Pharma Inc.
• Celularity Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 羊膜市場2029年：新たな機会を提供する国
• 羊膜市場2029年：新たな機会を提供するセグメント
• 羊膜市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The amniotic membrane, situated as the deepest layer of the placenta, comprises an avascular stromal matrix and a substantial foundation membrane. With numerous applications in regenerative medicine, it serves as a dressing in various surgical subspecialties to facilitate wound healing and reduce inflammation.

The primary products derived from the amniotic membrane include cryopreserved amniotic membrane and lyophilization amniotic membrane. Lyophilization amniotic membrane involves the preservation process of freezing something rapidly and then subjecting it to a vacuum to remove ice. These products find diverse applications in surgical wounds, ophthalmology, and other medical fields. They are utilized in hospitals, ambulatory surgical centers (ASCs), specialty clinics, as well as research and academic institutes.

The amniotic membrane market research report is one of a series of new reports from The Business Research Company that provides amniotic membrane market statistics, including amniotic membrane industry global market size, regional shares, competitors with an amniotic membrane market share, detailed amniotic membrane market segments, market trends and opportunities, and any further data you may need to thrive in the amniotic membrane industry. This amniotic membrane market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The amniotic membrane market size has grown strongly in recent years. It will grow from$1.75 billion in 2024 to $1.89 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increasing patient demand, medical advancements, wound healing research, surgical innovations, burn treatment evolution

The amniotic membrane market size is expected to see rapid growth in the next few years. It will grow to $2.86 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to expanding applications, regenerative medicine growth, rising prevalence of chronic diseases, aging population demographics, clinical trials and research. Major trends in the forecast period include patient-centric healthcare, focus on anti-inflammatory effects, clinical validation and research, biological dressing innovations, customized and personalized treatments.

The anticipated rise in transplant procedures is expected to accelerate the growth of the amniotic membrane market in the near future. Transplantation involves the surgical transfer of tissue or an organ from one person (the donor) to another recipient. The amniotic membrane is employed in a variety of transplant surgeries. For instance, the NHS Blood and Transplant Annual Report and Accounts 2022-23 reported a 2% increase in the number of donors and a 5% rise in transplants in the UK during 2022-23 compared to the prior year. Thus, the increasing volume of transplants is driving the development of the amniotic membrane market.

The rising prevalence of chronic diseases is anticipated to drive the growth of the amniotic membrane market in the future. Chronic diseases are illnesses that persist for three months or longer and may worsen over time. The amniotic membrane's unique characteristics, including its anti-inflammatory and regenerative properties, make it effective in managing chronic conditions, minimizing complications, and repairing tissue damage. Its versatility allows it to be used across various medical fields, addressing the demand for effective treatments for chronic diseases. For example, a report from the World Health Organization, a United Nations agency based in Switzerland, projects that by 2050, there will be over 35 million new cancer cases, reflecting a 77% increase from the estimated 20 million cases in 2022. Therefore, the growing prevalence of chronic diseases is fueling the expansion of the amniotic membrane market.

Major players in the amniotic membrane market are strategically focusing on the development of new surgical wound solutions to gain a competitive advantage. Surgical wounds are intentional incisions or injuries made during surgical procedures. An example of this trend is observed in the actions of MiMedx Group Inc., a biomedical company based in Georgia. In September 2022, the company launched AMNIOEFFECT, a tri-layer PURION processed human tissue allograft specifically designed for surgical procedures. This product supports the healing cascade by facilitating the development of granulation tissue. Comprising the amnion, intermediate, and chorion membrane layers of the placenta, AMNIOEFFECT enhances MiMedx's Surgical Recovery product portfolio. It provides a biocompatible human extracellular matrix (ECM) and retains over 300 regulatory proteins. The tissue offers superior handling characteristics, enabling surgeons to secure tissue in place with sutures for addressing surgical wounds.

Major companies in the amniotic membrane market are also investing in the development of new allografts to maintain a competitive edge. Allografts involve the transplantation of tissues or organs from one individual (the donor) to another individual (the recipient) within the same species. Amnio Technology LLC, a US-based biotechnology company, exemplifies this trend. In February 2022, the company launched two innovative dual-layer amniotic tissue allografts-PalinGen Dual-Layer Membrane and Dual Layer PalinGen X-Membrane. These products, designed for patients with non-healing acute and chronic wounds, complex surgical wounds, and burns, offer enhanced durability and slower resorption. Their dual-layered structure allows for unidirectional application with two outward-facing epithelial sides, contributing to improved wound management. Developed through the proprietary Advantek process, these allografts preserve the natural tissue's extracellular matrix components and regulatory proteins.

In March 2022, Thea Pharma Inc., a pharmaceutical company based in the U.S., acquired Akorn Operating Company LLC for an undisclosed sum. This acquisition is part of Thea Pharma's strategy to strengthen its presence in the U.S. eye care market by expanding its product range for eye care professionals and improving access to innovative treatments for conditions such as glaucoma, dry eye, allergies, and inflammation. Akorn Operating Company LLC specializes in the development, manufacturing, and marketing of both branded and generic pharmaceuticals.

Major companies operating in the amniotic membrane market include Alliqua BioMedical Inc., Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, Rivela DermaScience, MiMedx Group Inc., Skye Biologics Inc., Amniox Medical Inc., Integra LifeSciences Co., Organogenesis Holdings Inc., Bio-Tissue Inc., Stryker Corporation, Osiris Therapeutics Inc., Tissue-Tech Inc., DermaSciences Inc., Laboratoire CCD, VIVEX Biologics Inc., Merakris Therapeutics Inc., Thea Pharma Inc., Celularity Inc., Corza Ophthalmology, LifeCell International Pvt. Ltd., Smith & Nephew, RTI Surgical, BioLab Sciences, Allosure Inc., FzioMed Inc.

North America was the largest region in the amniotic membrane market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic membrane market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the amniotic membrane market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The amniotic membrane market consists of sales of epithelium, basement membrane, and stroma. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Amniotic Membrane Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on amniotic membrane market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for amniotic membrane ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The amniotic membrane market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Cryopreserved Amniotic Membrane; Lyophilization Amniotic Membrane
• 2) By Application: Surgical Wounds; Ophthalmology; Other Applications
• 3) By End-Use: Hospitals; Ambulatory Surgical Centers (ASCs); Other End-Users
• Subsegments:
• 1) By Cryopreserved Amniotic Membrane: Dehydrated Cryopreserved Amniotic Membrane; Fresh Cryopreserved Amniotic Membrane
• 2) By Lyophilization Amniotic Membrane: Sterilized Lyophilized Amniotic Membrane; Non-Sterilized Lyophilized Amniotic Membrane
• Companies Mentioned: Alliqua BioMedical Inc.; Amnio Technology LLC; Applied Biologics LLC; Human Regenerative Technologies LLC; Rivela DermaScience
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Amniotic Membrane Market Characteristics

3. Amniotic Membrane Market Trends And Strategies

4. Amniotic Membrane Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Amniotic Membrane Growth Analysis And Strategic Analysis Framework

• 5.1. Global Amniotic Membrane PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Amniotic Membrane Market Growth Rate Analysis
• 5.4. Global Amniotic Membrane Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Amniotic Membrane Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Amniotic Membrane Total Addressable Market (TAM)

6. Amniotic Membrane Market Segmentation

• 6.1. Global Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cryopreserved Amniotic Membrane
• Lyophilization Amniotic Membrane
• 6.2. Global Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Wounds
• Ophthalmology
• Other Applications
• 6.3. Global Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Other End-Users
• 6.4. Global Amniotic Membrane Market, Sub-Segmentation Of Cryopreserved Amniotic Membrane, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dehydrated Cryopreserved Amniotic Membrane
• Fresh Cryopreserved Amniotic Membrane
• 6.5. Global Amniotic Membrane Market, Sub-Segmentation Of Lyophilization Amniotic Membrane, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sterilized Lyophilized Amniotic Membrane
• Non-Sterilized Lyophilized Amniotic Membrane

7. Amniotic Membrane Market Regional And Country Analysis

• 7.1. Global Amniotic Membrane Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Amniotic Membrane Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Amniotic Membrane Market

• 8.1. Asia-Pacific Amniotic Membrane Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Amniotic Membrane Market

• 9.1. China Amniotic Membrane Market Overview
• 9.2. China Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Amniotic Membrane Market

• 10.1. India Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Amniotic Membrane Market

• 11.1. Japan Amniotic Membrane Market Overview
• 11.2. Japan Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Amniotic Membrane Market

• 12.1. Australia Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Amniotic Membrane Market

• 13.1. Indonesia Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Amniotic Membrane Market

• 14.1. South Korea Amniotic Membrane Market Overview
• 14.2. South Korea Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Amniotic Membrane Market

• 15.1. Western Europe Amniotic Membrane Market Overview
• 15.2. Western Europe Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Amniotic Membrane Market

• 16.1. UK Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Amniotic Membrane Market

• 17.1. Germany Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Amniotic Membrane Market

• 18.1. France Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Amniotic Membrane Market

• 19.1. Italy Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Amniotic Membrane Market

• 20.1. Spain Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Amniotic Membrane Market

• 21.1. Eastern Europe Amniotic Membrane Market Overview
• 21.2. Eastern Europe Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Amniotic Membrane Market

• 22.1. Russia Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Amniotic Membrane Market

• 23.1. North America Amniotic Membrane Market Overview
• 23.2. North America Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Amniotic Membrane Market

• 24.1. USA Amniotic Membrane Market Overview
• 24.2. USA Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Amniotic Membrane Market

• 25.1. Canada Amniotic Membrane Market Overview
• 25.2. Canada Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Amniotic Membrane Market

• 26.1. South America Amniotic Membrane Market Overview
• 26.2. South America Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Amniotic Membrane Market

• 27.1. Brazil Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Amniotic Membrane Market

• 28.1. Middle East Amniotic Membrane Market Overview
• 28.2. Middle East Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Amniotic Membrane Market

• 29.1. Africa Amniotic Membrane Market Overview
• 29.2. Africa Amniotic Membrane Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Amniotic Membrane Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Amniotic Membrane Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Amniotic Membrane Market Competitive Landscape And Company Profiles

• 30.1. Amniotic Membrane Market Competitive Landscape
• 30.2. Amniotic Membrane Market Company Profiles
  • 30.2.1. Alliqua BioMedical Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Amnio Technology LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Applied Biologics LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Human Regenerative Technologies LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Rivela DermaScience Overview, Products and Services, Strategy and Financial Analysis

31. Amniotic Membrane Market Other Major And Innovative Companies

• 31.1. MiMedx Group Inc.
• 31.2. Skye Biologics Inc.
• 31.3. Amniox Medical Inc.
• 31.4. Integra LifeSciences Co.
• 31.5. Organogenesis Holdings Inc.
• 31.6. Bio-Tissue Inc.
• 31.7. Stryker Corporation
• 31.8. Osiris Therapeutics Inc.
• 31.9. Tissue-Tech Inc.
• 31.10. DermaSciences Inc.
• 31.11. Laboratoire CCD
• 31.12. VIVEX Biologics Inc.
• 31.13. Merakris Therapeutics Inc.
• 31.14. Thea Pharma Inc.
• 31.15. Celularity Inc.

32. Global Amniotic Membrane Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Amniotic Membrane Market

34. Recent Developments In The Amniotic Membrane Market

35. Amniotic Membrane Market High Potential Countries, Segments and Strategies

• 35.1 Amniotic Membrane Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Amniotic Membrane Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Amniotic Membrane Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer